[Sirolimus inhibits the differentiation, proliferation and migration of endothelial progenitor cells in vitro]
Po Zhang1, Lan Huang, Guang-xu Zhu
1Cardiovascular Center of PLA, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.
Objective:
To investigate the effect of sirolimus on differentiation, proliferation, adhesion and migration of endothelial progenitor cells (EPC) in vitro.
Methods:
(1) Mononuclear cells (MNC) were isolated from rat bone marrow by Ficoll density gradient centrifugation and cultured on fibronectin-coated culture dishes with or without sirolimus (0.01 - 100 ng/ml) for 12 days. (2) After 8 days cultured, attached cells were treated with sirolimus (0.1 - 200 ng/ml) or vehicle for various time points (12 h, 24 h, 48 h and 96 h). EPC were identified as adherent cells double positive stained for FITC-UEA-I and DiI-acLDL under laser confocal immunofluence microscope. EPC proliferation, migration were assayed with MTT assay and modified Boyden chamber assay respectively.
Results:
EPC number differentiated from MNC at 12 days was significantly lower in sirolimus treated cells in a dose-dependent manner than that of vehicle-treated cells. Sirolimus also significantly inhibited the proliferative, migratory and adhesive capacity of EPC in a time and dose dependent manner.
Conclusion:
Present results suggested that sirolimus could inhibit EPC differentiation from MNC and reduce the proliferation, migration and adhesion capacities of EPC.
Insights
Sirolimus inhibits endothelial progenitor cell (EPC) differentiation from mononuclear cells (MNC). This drug also reduces EPC proliferation, migration, and adhesion in vitro, impacting cell function.
Area of Science:
- Cell Biology
- Pharmacology
- Regenerative Medicine
Context:
- Endothelial progenitor cells (EPCs) are crucial for vascular repair and angiogenesis.
- Understanding the effects of immunosuppressants like sirolimus on EPC function is vital for clinical applications.
- This study explores the in vitro impact of sirolimus on key EPC behaviors.
Purpose:
- To investigate the effects of sirolimus on the differentiation, proliferation, adhesion, and migration of rat endothelial progenitor cells (EPCs) in vitro.
- To determine the dose- and time-dependent responses of EPCs to sirolimus treatment.
Summary:
- Sirolimus significantly inhibited EPC differentiation from mononuclear cells (MNCs) in a dose-dependent manner.
- The drug markedly reduced EPC proliferation, migration, and adhesion capabilities in a time- and dose-dependent fashion.
- EPCs were identified using immunofluorescence staining for FITC-UEA-I and DiI-acLDL.
Impact:
- Sirolimus demonstrates inhibitory effects on crucial EPC functions, including differentiation and cellular activities.
- These findings suggest potential implications for sirolimus use in contexts involving vascular repair and regeneration.
- Further research is warranted to elucidate the clinical relevance of these in vitro observations.
Related Concept Videos
iPS Cell Differentiation
Regulation of Hematopoietic Stem Cells
Mesenchymal Stem Cells


